BioSpace News Archive

Drug Development

First Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma

Innate Pharma SA announced that the first patient was dosed in a Sanofi-sponsored Phase 1/2 clinical trial, evaluating SAR’514 / IPH6401 in relapsed/refractory Multiple Myeloma and Relapsed/Refractory Light-chain Amyloidosis 1.

July 11, 2023
·
6 min read
Deals

MedGenome acquires Illumina’s NovaSeq X Plus and Launches Genome Sequencing Test KaryoSeq

MedGenome, a leading global Genomic Diagnostic and Research Services company in South Asia, becomes the first to offer advanced genomics services using Illumina’s NovaSeq X Plus in South Asia.

July 11, 2023
·
4 min read
BioForest

Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership

Evotec SE announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

July 11, 2023
·
5 min read
U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri’s PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation Syndrome

Pluri Inc. announced that it has signed a three year $4.2M contract with the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

July 11, 2023
·
9 min read
metabion expands production capacity for diagnostic and therapeutic oligonucleotides in Munich East

metabion has increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives thereof to support the rising demand in Europe and worldwide.

July 11, 2023
·
2 min read
Drug Development

AlzeCure Publishes New Disease Modifying Data with NeuroRestore ACD856 Against Alzheimer’s and Cognitive Disorders

AlzeCure Pharma AB announced that a new scientific article has been published on NeuroRestore ACD856 and preclinical results supporting its disease-modifying effect.

July 11, 2023
·
6 min read
Business

Sosei Heptares Webinar Presentation for Q2 FY2023 Financial Results

Sosei Group Corporation will announce its earnings results and present operational highlights for the 6 months ended 30 June 2023 on Friday, 4 August 2023.

July 11, 2023
·
2 min read
Hummingbird Diagnostics Announces Publication of miLung Small RNA-Based Blood Test for Early Detection of Lung Cancer in the Journal of Thoracic Oncology

Hummingbird Diagnostics GmbH announced a publication in the Journal of Thoracic Oncology following a poster presentation at the American Society for Clinical Oncology 2023 Annual Meeting on the miLung small RNA blood test for early-stage lung cancer detection.

July 11, 2023
·
3 min read
BioMidwest

SoftWave TRT Selected to Exhibit DermaGold at Vizient Innovative Technology Exchange

SoftWave TRT has been selected to exhibit the DermaGold portfolio, their patented low intensity electrohydraulic shockwave technology for advanced wound care, at the Vizient Innovative Technology Exchange.

July 11, 2023
·
2 min read
Drug Development

Enterome announces first patient dosed in Phase 2 trial with OncoMimics™ immunotherapy EO2040 in Colorectal Cancer with ctDNA-defined Minimal Residual Disease

Enterome announces that the first patient has been dosed at The University of Texas MD Anderson Cancer Center in the Phase 2 ‘CLAUDE’ trial evaluating EO2040, the Company’s fourth OncoMimics™ immunotherapy candidate to enter clinical development.

July 11, 2023
·
6 min read